Form 4 for EW Edwards Lifesciences
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-22 · accession 0001225208-26-002408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-22 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $79.78 | -176 | 9,089 | -2% | -$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-22 | F | D | 176 | $79.78 | 9,089.48 | D | — | — |